Ann: Proteomics secures major contract - nears cash flow positive, page-62

Hi Eqz and fellow PIQ holders,

The 30 June 2018 accounts tell us what the R&D payment should be as it was accrued in the final accounts for the year. That figure is $844,123 which is their best estimate as at 30 June 2018 before the claim is submitted. Last year they received $786,225 even though in the accounts they were accruing for $790,751 which is only off by a half of 1 percent.

It will not effect profitability as it is already accrued and sitting on the balance sheet in current assets and it will just move from that asset to cash, the ultimate asset class.

The announcement that they had received the cash was on the 10th of October last year so it should be pretty soon this year if it follows a similar patern.